Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicenter Observational Open Program. Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril in Patients With Arterial Hypertension and Stable CAD in Daily Clinical Practice (STYLE)

Trial Profile

Multicenter Observational Open Program. Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril in Patients With Arterial Hypertension and Stable CAD in Daily Clinical Practice (STYLE)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Jan 2019

At a glance

  • Drugs Bisoprolol/perindopril (Primary)
  • Indications Angina pectoris; Coronary artery disease; Essential hypertension
  • Focus Therapeutic Use
  • Acronyms STYLE
  • Sponsors Servier Russia
  • Most Recent Events

    • 10 Jan 2019 Status changed from not yet recruiting to recruiting.
    • 16 Nov 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top